STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk)
a Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs
L.J. Seppala (Amsterdam UMC)
Mirko Petrovic (Universiteit Gent)
J. Ryg (Odense University Hospital, University of Southern Denmark)
G. Bahat (Istanbul University)
E. Topinkova (Charles University, South Bohemian University, Ceske Budejovice)
K. Szczerbińska (Jagiellonian University)
T.J.M. van der Cammen (TU Delft - Industrial Design Engineering)
S. Hartikainen (University of Eastern Finland - Kuopio Campus)
B. Ilhan ( University of MedicalSciences, Istanbul)
undefined More Authors (External organisation)
More Info
expand_more
Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.
Abstract
BACKGROUND: Healthcare professionals are often reluctant to deprescribe fall-risk-increasing drugs (FRIDs). Lack of knowledge and skills form a significant barrier and furthermore, there is no consensus on which medications are considered as FRIDs despite several systematic reviews. To support clinicians in the management of FRIDs and to facilitate the deprescribing process, STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk) and a deprescribing tool were developed by a European expert group. METHODS: STOPPFall was created by two facilitators based on evidence from recent meta-analyses and national fall prevention guidelines in Europe. Twenty-four panellists chose their level of agreement on a Likert scale with the items in the STOPPFall in three Delphi panel rounds. A threshold of 70% was selected for consensus a priori. The panellists were asked whether some agents are more fall-risk-increasing than others within the same pharmacological class. In an additional questionnaire, panellists were asked in which cases deprescribing of FRIDs should be considered and how it should be performed. RESULTS: The panellists agreed on 14 medication classes to be included in the STOPPFall. They were mostly psychotropic medications. The panellists indicated 18 differences between pharmacological subclasses with regard to fall-risk-increasing properties. Practical deprescribing guidance was developed for STOPPFall medication classes. CONCLUSION: STOPPFall was created using an expert Delphi consensus process and combined with a practical deprescribing tool designed to optimise medication review. The effectiveness of these tools in falls prevention should be further evaluated in intervention studies.
help_outline